8-K
filed June 23, 2023, 7:59 PM ET
ticker MBIO
CIK 0001680048
other material
confidence high
sentiment neutral
materiality 0.30
Mustang Bio stockholders approve ESPP amendment increasing shares to 466,666
MUSTANG BIO, INC.
- Stockholders approved ESPP amendment increasing shares from 66,666 to 466,666 and purchase right to 5,000.
- Six directors elected: Weiss, Rosenwald, Herskowitz, Litchman, Chill, Zelefsky (all >10.1M votes for).
- KPMG ratified as independent auditor for FY2023 (13.4M for, 68K against).
- Advisory say-on-pay passed (10.3M for); frequency of vote set at every 3 years (9.9M votes).
- Approximately 87% of votes represented at the meeting, constituting a quorum.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
MUSTANG BIO, INC. shareholders approved Amendment to 2019 ESPP to increase shares available for issuance by 400,000 and increase purchase right limit to 5,000 shares at the 2023-06-21 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
Proposal 5 The vote with respect to the approval of an amendment to Mustang’s ESPP were as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 10,587,920 136,816 16,646 2,772,190
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
MUSTANG BIO, INC. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for year ending December 31, 2023 at the 2023-06-21 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
Proposal 2 The votes with respect to the ratification of KPMG LLP as Mustang’s independent registered accounting firm for the year ending December 31, 2023 were as follows: Total Votes For Total Votes Against Abstentions 13,416,567 67,990 29,015
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
MUSTANG BIO, INC. shareholders approved Election of six directors to hold office until the 2024 annual meeting at the 2023-06-21 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
Proposal 1 The votes with respect to the election of six directors to hold office until the 2024 annual meeting were as follows: Director For Withheld Broker Non-Votes Michael S. Weiss 10,157,538 583,844 2,772,190 Lindsay A. Rosenwald, M.D. 10,155,900 585,482 2,772,190 Neil Herskowitz 10,319,736 421,646 2,772,190 Manuel Litchman, M.D. 10,229,325 512,057 2,772,190 Adam Chill 10,465,392 275,990 2,772,190 Michael Zelefsky, M.D. 10,465,460 275,922 2,772,190
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
MUSTANG BIO, INC. shareholders approved Advisory vote on frequency of say-on-pay votes (every three years) at the 2023-06-21 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
Proposal 4 The stockholders recommended a frequency of every three years for holding an advisory vote on the compensation of the Company’s named executive officers. The results of the advisory vote were as follows: 1 Year 2 Years 3 Years Abstentions 765,968 22,813 9,934,636 17,965
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
MUSTANG BIO, INC. shareholders approved Approval of compensation of named executive officers, advisory vote at the 2023-06-21 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
Proposal 3 The votes with respect to the approval of the compensation of the named executive officers, in an advisory vote, were as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 10,275,332 415,125 50,925 2,772,190
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.